New Key Statistics Module, Z-Score and F-Score
DHA:ORIONPHARM Key Ratios
| Market Cap BDT M | 15,795.00 |
| Enterprise Value BDT M | 37,883.75 |
| P/E(ttm) | 34.68 |
| PE Ratio without NRI | 34.70 |
| Forward PE Ratio | -- |
| Price/Book | 0.79 |
| Price/Sales | 1.42 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | 0.49 |
| Revenue (TTM) BDT M | 11,758.00 |
| EPS (TTM) BDT | 2.06 |
| Beneish M-Score | -2.81 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -3.90 |
| y-y EBITDA Growth Rate % | -35.40 |
| EV-to-EBIT | 56.00 |
| EV-to-EBITDA | 30.63 |
| PEG | -- |
| Shares Outstanding M | 234.00 |
| Net Margin (%) | 4.08 |
| Operating Margin % | 5.64 |
| Pre-tax Margin (%) | 5.00 |
| Quick Ratio | 1.36 |
| Current Ratio | 1.51 |
| ROA % (ttm) | 0.89 |
| ROE % (ttm) | 2.29 |
| ROIC % (ttm) | 1.23 |
| Dividend Yield % | 1.47 |
| Altman Z-Score | 0.91 |
| Piotroski F-Score | 6.00 |
| Positive ROA | Y |
| Positive CFROA | Y |
| Higher ROA y-y | N |
| Cash flow > Earnings | Y |
| Lower Leverage y-y | Y |
| Higher Current Ratio y-y | N |
| Less Shares Outstanding y-y | Y |
| Gross Margin Increase y-y | Y |
| Higher Asset Turnover y-y | N |
DHA:ORIONPHARM Number of Guru Trades
DHA:ORIONPHARM Volume of Guru Trades
Gurus Latest Trades with DHA:ORIONPHARM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
DHA:ORIONPHARM is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers